Coming soon: Read the full case study (PDF).
 EngenderHealth. Balancing the Scales: Expanding Treatment for Pregnant Women with Life-Threatening Hypertensive Conditions in Developing Countries; A Report on Barriers and Solutions to Treat Pre-eclampsia & Eclampsia. Engender Health; 2007. http://www.engenderhealth.org/ files/pubs/maternal-health/EngenderHealth-Eclampsia-Report. pdf. Last accessed March 23, 2012.
 USAID, JHPIEGO. Rapid Landscape Analysis of technologies for postpartum hemorrhage. Conducted by JHPIEGO/Accelovate for USAID at the Technologies for Health Consultative Meeting - MNCH Pathways. Unpublished. 2012.
 WHO. WHO Model List of Essential Medicines (March 2011), 17th
edition. Available at: http://whqlibdoc.who.int/hq/2011/a95053_eng.pdf. Accessed March 26,2011
 USAID, PATH. Rapid Landscape Analysis of Technologies for Preeclampsia/Eclampsia. Presented at: Technologies for Health Consultative Meeting—MNCH Pathways, February 15, 2012; Washington, DC.
 Fujioka A, Smith J. Prevention and Management of Postpartum Hemorrhage and Pre-Eclampsia/Eclampsia: National Programs in Selected USAID Program-Supported Countries. Maternal and Child Health Integrated Program (MCHIP); 2011. Available at: http://www.k4health.org/system/files/PPH_PEE%20Program%20Status%20Report.pdf
. Accessed February 2012.
 UNFPA, Lao PDR Ministry of Health. Review of Current Status in Access to a Core Set of Critical, Life-saving Medicines for Maternal/Reproductive Health in Lao PDR: Mission Report. UNFPA and Lao PDR Ministry of Health; 2008.
 United Nations Population Fund (UNFPA), WHO. Joint UNFPA/WHO Mission in Collaboration with the Ministry of Health to Review the Current Status of Access to a Core Set of Critical, Life-saving Maternal/Reproductive Health Medicines in Mongolia. 2009. Available at: http://digicollection.org/hss/documents/s16325e/s16325e.pdf
. Accessed February 2012.
 MSH. Active Management of the Third Stage of Labor in Health Care Facilities: Results of a National Study in Ghana, 2007. Arlington, VA: MSH, Prevention of Postpartum Hemorrhage Initiative; 2008.
 Barua A, Shuchita M, Bracken H, Easterling T, Winikoff B. Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia in 3 Indian hospitals. The International Journal of Gynecology & Obstetrics. 2011; 115(2):231–234.
 Duley L, Farrell B, Spark P, Roberts B, Watkins K, Bricker L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359:1877-90